Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
06. Dezember 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 7776
Artikel 1 - 20 / 155502
A more selective risk-stratified, machine learning based, lung cancer thromboprophylaxis protocol following vats segmentectomy: a prospective cohort study.
Int J Surg
Wang J, Wang D, Cui S, Yang S, Zhao Q, Chen Q, Miao JB, Fu YL, Li H, Hu B.
PMID: 41351270 [PubMed - as supplied by publisher]
Primary Hepatic Neuroendocrine Tumour Misdiagnosed as Liver Metastases of Lung Adenocarcinoma: A Rare Case.
J Coll Physicians Surg Pak
Liu J, Ye L, Liu Q.
PMID: 41351108 [PubMed - indexed for MEDLINE]
Development and Validation of a Nomogram for Predicting Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anlotinib.
J Coll Physicians Surg Pak
Wu Z, Zhou P, Zhao Y, Wang J, Gao S.
PMID: 41351099 [PubMed - indexed for MEDLINE]
The risk of symptomatic radiation pneumonitis in small cell lung cancer patients following sequential immunochemotherapy and radiotherapy: a multicenter retrospective cohort study.
Radiat Oncol
Liu Y, Zhang J, Zhang M, Wu W, Zhang H, Yin H.
PMID: 41350861 [PubMed - as supplied by publisher]
Retrospective analysis of the clinical features and prognosis of idiopathic pulmonary fibrosis combined with lung cancer.
BMC Cancer
Fu S, Li L, Ou Z, Lin C.
PMID: 41350847 [PubMed - indexed for MEDLINE]
Pathogenic mechanisms and resistance profiles of microbial pulmonary infections in lung cancer: a systematic review.
BMC Infect Dis
Sheervalilou M, Ghanei M, Arabfard M.
PMID: 41350628 [PubMed - as supplied by publisher]
Efficacy and safety of natural killer cell therapy for the treatment of advanced non-small cell lung cancer: A meta-analysis and systematic review.
Immunol Res
Li Z, Wang X, Chen S, Zhang P, Wang X, Ni X, Mou C.
PMID: 41350490 [PubMed - indexed for MEDLINE]
Exploring healthcare providers' perceptions of virtual reality in lung cancer treatment preparedness: a mixed-methods feasibility study for the development of EveryBreathMatters.
Sci Rep
Elkefi S, Wu R, Feiner SK, Chen L, Hembroff G, Matthews AK.
PMID: 41350374 [PubMed - as supplied by publisher]
Non-small cell lung cancer subtype classification based on cross-scale multi-instance learning.
Sci Rep
Jiang P, Chen W, Zheng G, Li X, Song X.
PMID: 41350354 [PubMed - indexed for MEDLINE]
Multicolor SERS-encoded immuno-cocktail for longitudinal precise tracking of CTCs phenotypes in lung cancer therapeutics.
Biosens Bioelectron
Fan M, Yu Z, Luo K, Chen P, Lin D, Lin Y, Lin X, Chen J, Feng S.
PMID: 41349442 [PubMed - as supplied by publisher]
Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan.
ESMO Open
Kawakami H, Uchino K, Hashimoto W, Muro K.
PMID: 41349223 [PubMed - as supplied by publisher]
Neoadjuvant Chemo-Immunotherapy for Surgically Resectable Non-Small Cell Lung Cancer: Balancing Promise and Pitfalls.
Clin Lung Cancer
Desai PA, Borghaei H, Edelman MJ.
PMID: 41349181 [PubMed - as supplied by publisher]
Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002-2022).
PLoS One
Dhouib W, Maatouk A, Bennasrallah C, Kacem M, Doghri S, Trigui A, Bouazizi M, Milad L, Ben Fredj M, Bouanène I, Abroug H, Rouatbi N, Zaied S, Mokni M, Belguith Sriha A, Zemni I.
PMID: 41348719 [PubMed - indexed for MEDLINE]
A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes.
PLoS One
Hobson LM, Martin RM, Smith-Byrne K, Davey Smith G, Hemani G, Gilbody JH, Yarmolinsky J, Bailey SER, Goudswaard LJ, Haycock PC.
PMID: 41348656 [PubMed - indexed for MEDLINE]
Letter to editor about Ultra-short-period perioperative pulmonary rehabilitation on short-term outcomes after surgery in smoking patients with lung cancer: a randomized clinical trial.
Int J Surg
Cao ZG.
PMID: 41347274 [PubMed - as supplied by publisher]
Chinese herbal injections combined with EGFR-TKIs for intervention of non-small cell lung cancer: a systematic review and meta-analysis.
Front Pharmacol
Yuan Z, Yan M, Wu T, Zhang G, Yang G, Wang X.
PMID: 41347160 [PubMed]
Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer.
Front Pharmacol
Xie X, Chen Q, Guo C, Zeng J, He Q.
PMID: 41347152 [PubMed]
Prognostic significance of the lymphocyte-to-high-density lipoprotein ratio in long-term efficacy of combined immunotherapy for advanced non-small cell lung cancer.
Front Oncol
Ma G, Ma L, Zhang Y, Chen Y, Zhang Y, Guo W, Yao Z, Ji G.
PMID: 41347091 [PubMed]
Application value of oral targeted drug management program led by specialist nurses in continuous nursing for lung cancer patients.
Front Med (Lausanne)
Zhang X, Lian T.
PMID: 41346998 [PubMed]
The role of preoperative lung rehabilitation training combined with nutritional intervention on surgical tolerance and accelerated recovery indicators in patients with moderate to severe COPD complicated with lung cancer.
Front Surg
Hu Y, Cheng Q, Guo Q.
PMID: 41346729 [PubMed]
Artikel 1 - 20 / 155502
Seite 1 von 7776
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung